Publicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (3)

2021

  1. Assessing blood-based biomarkers to define a therapeutic window for natalizumab

    Journal of Personalized Medicine, Vol. 11, Núm. 12

  2. Direct costs of relapses in patients with relapsing-remitting multiple sclerosis

    Neurology Perspectives, Vol. 1, Núm. 3, pp. 160-169

2018

  1. Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

    Multiple Sclerosis Journal, Vol. 24, Núm. 14, pp. 1843-1851